Effect of Repetitive Transcranial Magnetic Stimulation (RTMS) on EEG Changes, Sleep, Physical Activity and Psychological States of Migraine: A Randomised Controlled Trial (Magnet-EM)
Abstract
Migraine is one of the leading causes of morbidity in the world and the cause of health care visits (Seidel et al 2017). Progression of the disease usually leads to unfavourable outcomes including medication overused and tendency towards psychiatric comorbidities. Moving towards preventive medicine, this study measured the effect of rTMS on migraine as secondary prevention. In this article, per protocol analysis was used. It is a double-blinded randomised, controlled trial Sixty-four migraine subjects were included in the analysis, randomized into placebo group and treatment group. Maximum Intensity of pulse is decided by muscle twitching when single pulse RTMS is delivered. 20 Hz RTMS is delivered on dorsolateral prefrontal cortex (dLPFC) with 80% of maximum intensity in 2000 pulse of 25 seconds interval for twenty minutes each session. EEG, PSQI, GPAQ and DASS-21 questionnaires and headache diary were delivered to the participants pre-and post-RTMS. The study found a statistically significant difference in the proportion of photic driving response pre-and post-rTMS, p = .005, ηp² = .336) in the rTMS group vs. placebo. Sleep, anxiety, physical activity and stress scores in the rTMS group vs placebo has no significant changes but there was a statistically significant reduction in the depression score (X² = 9.60, p= 0.022). To conclude, rTMS on dLPFC may offer beneficial effects to reduce depressive symptoms in migraine. Although this is an early finding, the current rTMS…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.